nodes	percent_of_prediction	percent_of_DWPC	metapath
Sumatriptan—migraine—Prednisone—systemic scleroderma	0.503	1	CpDpCtD
Sumatriptan—ABCG2—Leflunomide—systemic scleroderma	0.0635	0.196	CbGbCtD
Sumatriptan—SLCO1B1—Mycophenolate mofetil—systemic scleroderma	0.0494	0.153	CbGbCtD
Sumatriptan—SLCO1A2—Prednisone—systemic scleroderma	0.0419	0.129	CbGbCtD
Sumatriptan—ABCG2—Mycophenolate mofetil—systemic scleroderma	0.0392	0.121	CbGbCtD
Sumatriptan—ABCB1—Lisinopril—systemic scleroderma	0.024	0.0742	CbGbCtD
Sumatriptan—SLCO1A2—Methotrexate—systemic scleroderma	0.021	0.0649	CbGbCtD
Sumatriptan—SLCO1B1—Methotrexate—systemic scleroderma	0.0198	0.0612	CbGbCtD
Sumatriptan—ABCB1—Captopril—systemic scleroderma	0.018	0.0555	CbGbCtD
Sumatriptan—ABCG2—Methotrexate—systemic scleroderma	0.0157	0.0486	CbGbCtD
Sumatriptan—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0141	0.0437	CbGbCtD
Sumatriptan—ABCB1—Prednisone—systemic scleroderma	0.0113	0.0349	CbGbCtD
Sumatriptan—HTR3A—myenteric nerve plexus—systemic scleroderma	0.00727	0.394	CbGeAlD
Sumatriptan—ABCB1—Methotrexate—systemic scleroderma	0.00567	0.0175	CbGbCtD
Sumatriptan—HTR1B—artery—systemic scleroderma	0.0016	0.0868	CbGeAlD
Sumatriptan—HTR1D—artery—systemic scleroderma	0.00155	0.084	CbGeAlD
Sumatriptan—HTR1B—blood vessel—systemic scleroderma	0.00125	0.0676	CbGeAlD
Sumatriptan—HTR1D—blood vessel—systemic scleroderma	0.00121	0.0655	CbGeAlD
Sumatriptan—HTR1D—connective tissue—systemic scleroderma	0.000619	0.0336	CbGeAlD
Sumatriptan—HTR3A—digestive system—systemic scleroderma	0.000551	0.0298	CbGeAlD
Sumatriptan—SLCO1B1—digestive system—systemic scleroderma	0.000534	0.0289	CbGeAlD
Sumatriptan—MAOA—connective tissue—systemic scleroderma	0.000472	0.0256	CbGeAlD
Sumatriptan—HTR3A—lung—systemic scleroderma	0.00046	0.0249	CbGeAlD
Sumatriptan—SLCO1A2—digestive system—systemic scleroderma	0.000435	0.0236	CbGeAlD
Sumatriptan—ABCB1—blood vessel—systemic scleroderma	0.000393	0.0213	CbGeAlD
Sumatriptan—SLCO1A2—lung—systemic scleroderma	0.000363	0.0197	CbGeAlD
Sumatriptan—MAOA—digestive system—systemic scleroderma	0.000341	0.0185	CbGeAlD
Sumatriptan—MAOA—tendon—systemic scleroderma	0.000324	0.0176	CbGeAlD
Sumatriptan—MAOA—lung—systemic scleroderma	0.000284	0.0154	CbGeAlD
Sumatriptan—DRD2—lung—systemic scleroderma	0.000281	0.0152	CbGeAlD
Sumatriptan—ABCG2—lung—systemic scleroderma	0.000247	0.0134	CbGeAlD
Sumatriptan—ABCB1—digestive system—systemic scleroderma	0.000146	0.00789	CbGeAlD
Sumatriptan—ABCB1—lung—systemic scleroderma	0.000122	0.00659	CbGeAlD
Sumatriptan—Body temperature increased—Azathioprine—systemic scleroderma	7.63e-05	0.000494	CcSEcCtD
Sumatriptan—Skin disorder—Lisinopril—systemic scleroderma	7.61e-05	0.000492	CcSEcCtD
Sumatriptan—Malaise—Mycophenolate mofetil—systemic scleroderma	7.59e-05	0.000491	CcSEcCtD
Sumatriptan—Hyperhidrosis—Lisinopril—systemic scleroderma	7.58e-05	0.00049	CcSEcCtD
Sumatriptan—Diarrhoea—Captopril—systemic scleroderma	7.57e-05	0.00049	CcSEcCtD
Sumatriptan—Decreased appetite—Mycophenolic acid—systemic scleroderma	7.56e-05	0.000489	CcSEcCtD
Sumatriptan—Vertigo—Mycophenolate mofetil—systemic scleroderma	7.56e-05	0.000489	CcSEcCtD
Sumatriptan—Syncope—Mycophenolate mofetil—systemic scleroderma	7.54e-05	0.000488	CcSEcCtD
Sumatriptan—Feeling abnormal—Leflunomide—systemic scleroderma	7.52e-05	0.000486	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	7.51e-05	0.000486	CcSEcCtD
Sumatriptan—Fatigue—Mycophenolic acid—systemic scleroderma	7.5e-05	0.000485	CcSEcCtD
Sumatriptan—Nausea—Mometasone—systemic scleroderma	7.48e-05	0.000484	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Leflunomide—systemic scleroderma	7.46e-05	0.000482	CcSEcCtD
Sumatriptan—Weight increased—Prednisone—systemic scleroderma	7.45e-05	0.000482	CcSEcCtD
Sumatriptan—Pain—Mycophenolic acid—systemic scleroderma	7.44e-05	0.000481	CcSEcCtD
Sumatriptan—Constipation—Mycophenolic acid—systemic scleroderma	7.44e-05	0.000481	CcSEcCtD
Sumatriptan—Palpitations—Mycophenolate mofetil—systemic scleroderma	7.43e-05	0.000481	CcSEcCtD
Sumatriptan—Weight decreased—Prednisone—systemic scleroderma	7.4e-05	0.000479	CcSEcCtD
Sumatriptan—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	7.39e-05	0.000478	CcSEcCtD
Sumatriptan—Hyperglycaemia—Prednisone—systemic scleroderma	7.38e-05	0.000478	CcSEcCtD
Sumatriptan—Cough—Mycophenolate mofetil—systemic scleroderma	7.34e-05	0.000475	CcSEcCtD
Sumatriptan—Hypotension—Lisinopril—systemic scleroderma	7.32e-05	0.000474	CcSEcCtD
Sumatriptan—Dizziness—Captopril—systemic scleroderma	7.32e-05	0.000473	CcSEcCtD
Sumatriptan—Liver function test abnormal—Methotrexate—systemic scleroderma	7.31e-05	0.000473	CcSEcCtD
Sumatriptan—Convulsion—Mycophenolate mofetil—systemic scleroderma	7.29e-05	0.000472	CcSEcCtD
Sumatriptan—Depression—Prednisone—systemic scleroderma	7.28e-05	0.000471	CcSEcCtD
Sumatriptan—Hypertension—Mycophenolate mofetil—systemic scleroderma	7.26e-05	0.00047	CcSEcCtD
Sumatriptan—Urticaria—Leflunomide—systemic scleroderma	7.24e-05	0.000469	CcSEcCtD
Sumatriptan—Abdominal pain—Leflunomide—systemic scleroderma	7.21e-05	0.000466	CcSEcCtD
Sumatriptan—Body temperature increased—Leflunomide—systemic scleroderma	7.21e-05	0.000466	CcSEcCtD
Sumatriptan—Acute coronary syndrome—Prednisone—systemic scleroderma	7.19e-05	0.000465	CcSEcCtD
Sumatriptan—Feeling abnormal—Mycophenolic acid—systemic scleroderma	7.17e-05	0.000464	CcSEcCtD
Sumatriptan—Arthralgia—Mycophenolate mofetil—systemic scleroderma	7.16e-05	0.000463	CcSEcCtD
Sumatriptan—Chest pain—Mycophenolate mofetil—systemic scleroderma	7.16e-05	0.000463	CcSEcCtD
Sumatriptan—Myalgia—Mycophenolate mofetil—systemic scleroderma	7.16e-05	0.000463	CcSEcCtD
Sumatriptan—Myocardial infarction—Prednisone—systemic scleroderma	7.15e-05	0.000463	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	7.14e-05	0.000462	CcSEcCtD
Sumatriptan—Anxiety—Mycophenolate mofetil—systemic scleroderma	7.14e-05	0.000462	CcSEcCtD
Sumatriptan—Hypersensitivity—Azathioprine—systemic scleroderma	7.11e-05	0.00046	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	7.11e-05	0.00046	CcSEcCtD
Sumatriptan—Discomfort—Mycophenolate mofetil—systemic scleroderma	7.08e-05	0.000458	CcSEcCtD
Sumatriptan—Paraesthesia—Lisinopril—systemic scleroderma	7.04e-05	0.000455	CcSEcCtD
Sumatriptan—Vomiting—Captopril—systemic scleroderma	7.04e-05	0.000455	CcSEcCtD
Sumatriptan—Dry mouth—Mycophenolate mofetil—systemic scleroderma	7e-05	0.000453	CcSEcCtD
Sumatriptan—Dyspnoea—Lisinopril—systemic scleroderma	6.99e-05	0.000452	CcSEcCtD
Sumatriptan—Rash—Captopril—systemic scleroderma	6.98e-05	0.000451	CcSEcCtD
Sumatriptan—Dermatitis—Captopril—systemic scleroderma	6.97e-05	0.000451	CcSEcCtD
Sumatriptan—Somnolence—Lisinopril—systemic scleroderma	6.97e-05	0.000451	CcSEcCtD
Sumatriptan—Headache—Captopril—systemic scleroderma	6.93e-05	0.000448	CcSEcCtD
Sumatriptan—Confusional state—Mycophenolate mofetil—systemic scleroderma	6.92e-05	0.000448	CcSEcCtD
Sumatriptan—Body temperature increased—Mycophenolic acid—systemic scleroderma	6.88e-05	0.000445	CcSEcCtD
Sumatriptan—Abdominal pain—Mycophenolic acid—systemic scleroderma	6.88e-05	0.000445	CcSEcCtD
Sumatriptan—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	6.87e-05	0.000444	CcSEcCtD
Sumatriptan—Oedema—Mycophenolate mofetil—systemic scleroderma	6.87e-05	0.000444	CcSEcCtD
Sumatriptan—Asthma—Methotrexate—systemic scleroderma	6.84e-05	0.000443	CcSEcCtD
Sumatriptan—Infection—Mycophenolate mofetil—systemic scleroderma	6.82e-05	0.000441	CcSEcCtD
Sumatriptan—Decreased appetite—Lisinopril—systemic scleroderma	6.81e-05	0.000441	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Lisinopril—systemic scleroderma	6.77e-05	0.000438	CcSEcCtD
Sumatriptan—Fatigue—Lisinopril—systemic scleroderma	6.76e-05	0.000437	CcSEcCtD
Sumatriptan—Shock—Mycophenolate mofetil—systemic scleroderma	6.75e-05	0.000437	CcSEcCtD
Sumatriptan—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	6.73e-05	0.000436	CcSEcCtD
Sumatriptan—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	6.72e-05	0.000435	CcSEcCtD
Sumatriptan—Hypersensitivity—Leflunomide—systemic scleroderma	6.72e-05	0.000435	CcSEcCtD
Sumatriptan—Pancreatitis—Methotrexate—systemic scleroderma	6.71e-05	0.000434	CcSEcCtD
Sumatriptan—Pain—Lisinopril—systemic scleroderma	6.7e-05	0.000434	CcSEcCtD
Sumatriptan—Constipation—Lisinopril—systemic scleroderma	6.7e-05	0.000434	CcSEcCtD
Sumatriptan—Tachycardia—Mycophenolate mofetil—systemic scleroderma	6.7e-05	0.000434	CcSEcCtD
Sumatriptan—Skin disorder—Mycophenolate mofetil—systemic scleroderma	6.67e-05	0.000431	CcSEcCtD
Sumatriptan—Bradycardia—Prednisone—systemic scleroderma	6.67e-05	0.000431	CcSEcCtD
Sumatriptan—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	6.64e-05	0.000429	CcSEcCtD
Sumatriptan—Diarrhoea—Azathioprine—systemic scleroderma	6.61e-05	0.000427	CcSEcCtD
Sumatriptan—Haemoglobin—Prednisone—systemic scleroderma	6.58e-05	0.000426	CcSEcCtD
Sumatriptan—Nausea—Captopril—systemic scleroderma	6.57e-05	0.000425	CcSEcCtD
Sumatriptan—Abdominal discomfort—Methotrexate—systemic scleroderma	6.56e-05	0.000424	CcSEcCtD
Sumatriptan—Haemorrhage—Prednisone—systemic scleroderma	6.55e-05	0.000424	CcSEcCtD
Sumatriptan—Asthenia—Leflunomide—systemic scleroderma	6.54e-05	0.000423	CcSEcCtD
Sumatriptan—Hallucination—Prednisone—systemic scleroderma	6.52e-05	0.000422	CcSEcCtD
Sumatriptan—Pancytopenia—Methotrexate—systemic scleroderma	6.5e-05	0.00042	CcSEcCtD
Sumatriptan—Feeling abnormal—Lisinopril—systemic scleroderma	6.46e-05	0.000418	CcSEcCtD
Sumatriptan—Pruritus—Leflunomide—systemic scleroderma	6.45e-05	0.000417	CcSEcCtD
Sumatriptan—Connective tissue disorder—Prednisone—systemic scleroderma	6.44e-05	0.000416	CcSEcCtD
Sumatriptan—Hypotension—Mycophenolate mofetil—systemic scleroderma	6.42e-05	0.000415	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Lisinopril—systemic scleroderma	6.41e-05	0.000415	CcSEcCtD
Sumatriptan—Dysuria—Methotrexate—systemic scleroderma	6.4e-05	0.000414	CcSEcCtD
Sumatriptan—Dizziness—Azathioprine—systemic scleroderma	6.39e-05	0.000413	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	6.26e-05	0.000405	CcSEcCtD
Sumatriptan—Photosensitivity reaction—Methotrexate—systemic scleroderma	6.24e-05	0.000404	CcSEcCtD
Sumatriptan—Asthenia—Mycophenolic acid—systemic scleroderma	6.24e-05	0.000404	CcSEcCtD
Sumatriptan—Diarrhoea—Leflunomide—systemic scleroderma	6.24e-05	0.000404	CcSEcCtD
Sumatriptan—Urticaria—Lisinopril—systemic scleroderma	6.23e-05	0.000403	CcSEcCtD
Sumatriptan—Abdominal pain—Lisinopril—systemic scleroderma	6.19e-05	0.000401	CcSEcCtD
Sumatriptan—Body temperature increased—Lisinopril—systemic scleroderma	6.19e-05	0.000401	CcSEcCtD
Sumatriptan—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	6.17e-05	0.000399	CcSEcCtD
Sumatriptan—Pruritus—Mycophenolic acid—systemic scleroderma	6.16e-05	0.000398	CcSEcCtD
Sumatriptan—Vomiting—Azathioprine—systemic scleroderma	6.14e-05	0.000397	CcSEcCtD
Sumatriptan—Eye disorder—Prednisone—systemic scleroderma	6.12e-05	0.000396	CcSEcCtD
Sumatriptan—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	6.12e-05	0.000396	CcSEcCtD
Sumatriptan—Somnolence—Mycophenolate mofetil—systemic scleroderma	6.1e-05	0.000395	CcSEcCtD
Sumatriptan—Drowsiness—Methotrexate—systemic scleroderma	6.1e-05	0.000395	CcSEcCtD
Sumatriptan—Rash—Azathioprine—systemic scleroderma	6.09e-05	0.000394	CcSEcCtD
Sumatriptan—Dermatitis—Azathioprine—systemic scleroderma	6.08e-05	0.000394	CcSEcCtD
Sumatriptan—Depression—Methotrexate—systemic scleroderma	6.08e-05	0.000393	CcSEcCtD
Sumatriptan—Flushing—Prednisone—systemic scleroderma	6.08e-05	0.000393	CcSEcCtD
Sumatriptan—Headache—Azathioprine—systemic scleroderma	6.05e-05	0.000391	CcSEcCtD
Sumatriptan—Dizziness—Leflunomide—systemic scleroderma	6.03e-05	0.00039	CcSEcCtD
Sumatriptan—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	5.97e-05	0.000386	CcSEcCtD
Sumatriptan—Diarrhoea—Mycophenolic acid—systemic scleroderma	5.95e-05	0.000385	CcSEcCtD
Sumatriptan—Angiopathy—Prednisone—systemic scleroderma	5.94e-05	0.000385	CcSEcCtD
Sumatriptan—Conjunctivitis—Methotrexate—systemic scleroderma	5.93e-05	0.000384	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	5.93e-05	0.000384	CcSEcCtD
Sumatriptan—Immune system disorder—Prednisone—systemic scleroderma	5.92e-05	0.000383	CcSEcCtD
Sumatriptan—Pain—Mycophenolate mofetil—systemic scleroderma	5.87e-05	0.00038	CcSEcCtD
Sumatriptan—Constipation—Mycophenolate mofetil—systemic scleroderma	5.87e-05	0.00038	CcSEcCtD
Sumatriptan—Arrhythmia—Prednisone—systemic scleroderma	5.85e-05	0.000379	CcSEcCtD
Sumatriptan—Sweating—Methotrexate—systemic scleroderma	5.85e-05	0.000378	CcSEcCtD
Sumatriptan—Haematuria—Methotrexate—systemic scleroderma	5.81e-05	0.000376	CcSEcCtD
Sumatriptan—Vomiting—Leflunomide—systemic scleroderma	5.8e-05	0.000375	CcSEcCtD
Sumatriptan—Hypersensitivity—Lisinopril—systemic scleroderma	5.77e-05	0.000374	CcSEcCtD
Sumatriptan—Dizziness—Mycophenolic acid—systemic scleroderma	5.75e-05	0.000372	CcSEcCtD
Sumatriptan—Epistaxis—Methotrexate—systemic scleroderma	5.75e-05	0.000372	CcSEcCtD
Sumatriptan—Rash—Leflunomide—systemic scleroderma	5.75e-05	0.000372	CcSEcCtD
Sumatriptan—Dermatitis—Leflunomide—systemic scleroderma	5.74e-05	0.000372	CcSEcCtD
Sumatriptan—Nausea—Azathioprine—systemic scleroderma	5.74e-05	0.000371	CcSEcCtD
Sumatriptan—Headache—Leflunomide—systemic scleroderma	5.71e-05	0.00037	CcSEcCtD
Sumatriptan—Erythema—Prednisone—systemic scleroderma	5.7e-05	0.000369	CcSEcCtD
Sumatriptan—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	5.66e-05	0.000366	CcSEcCtD
Sumatriptan—Asthenia—Lisinopril—systemic scleroderma	5.62e-05	0.000364	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	5.61e-05	0.000363	CcSEcCtD
Sumatriptan—Pruritus—Lisinopril—systemic scleroderma	5.54e-05	0.000359	CcSEcCtD
Sumatriptan—Vomiting—Mycophenolic acid—systemic scleroderma	5.53e-05	0.000358	CcSEcCtD
Sumatriptan—Haemoglobin—Methotrexate—systemic scleroderma	5.5e-05	0.000356	CcSEcCtD
Sumatriptan—Rash—Mycophenolic acid—systemic scleroderma	5.49e-05	0.000355	CcSEcCtD
Sumatriptan—Dermatitis—Mycophenolic acid—systemic scleroderma	5.48e-05	0.000355	CcSEcCtD
Sumatriptan—Haemorrhage—Methotrexate—systemic scleroderma	5.47e-05	0.000354	CcSEcCtD
Sumatriptan—Urticaria—Mycophenolate mofetil—systemic scleroderma	5.45e-05	0.000353	CcSEcCtD
Sumatriptan—Headache—Mycophenolic acid—systemic scleroderma	5.45e-05	0.000353	CcSEcCtD
Sumatriptan—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	5.43e-05	0.000351	CcSEcCtD
Sumatriptan—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	5.43e-05	0.000351	CcSEcCtD
Sumatriptan—Nausea—Leflunomide—systemic scleroderma	5.42e-05	0.00035	CcSEcCtD
Sumatriptan—Diarrhoea—Lisinopril—systemic scleroderma	5.36e-05	0.000347	CcSEcCtD
Sumatriptan—Ill-defined disorder—Prednisone—systemic scleroderma	5.29e-05	0.000342	CcSEcCtD
Sumatriptan—Visual impairment—Methotrexate—systemic scleroderma	5.28e-05	0.000341	CcSEcCtD
Sumatriptan—Anaemia—Prednisone—systemic scleroderma	5.27e-05	0.000341	CcSEcCtD
Sumatriptan—Agitation—Prednisone—systemic scleroderma	5.24e-05	0.000339	CcSEcCtD
Sumatriptan—Angioedema—Prednisone—systemic scleroderma	5.21e-05	0.000337	CcSEcCtD
Sumatriptan—Dizziness—Lisinopril—systemic scleroderma	5.18e-05	0.000335	CcSEcCtD
Sumatriptan—Nausea—Mycophenolic acid—systemic scleroderma	5.17e-05	0.000334	CcSEcCtD
Sumatriptan—Malaise—Prednisone—systemic scleroderma	5.14e-05	0.000333	CcSEcCtD
Sumatriptan—Vertigo—Prednisone—systemic scleroderma	5.12e-05	0.000331	CcSEcCtD
Sumatriptan—Eye disorder—Methotrexate—systemic scleroderma	5.12e-05	0.000331	CcSEcCtD
Sumatriptan—Syncope—Prednisone—systemic scleroderma	5.11e-05	0.000331	CcSEcCtD
Sumatriptan—Tinnitus—Methotrexate—systemic scleroderma	5.1e-05	0.00033	CcSEcCtD
Sumatriptan—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	5.06e-05	0.000327	CcSEcCtD
Sumatriptan—Loss of consciousness—Prednisone—systemic scleroderma	5.01e-05	0.000324	CcSEcCtD
Sumatriptan—Vomiting—Lisinopril—systemic scleroderma	4.98e-05	0.000322	CcSEcCtD
Sumatriptan—Angiopathy—Methotrexate—systemic scleroderma	4.97e-05	0.000321	CcSEcCtD
Sumatriptan—Immune system disorder—Methotrexate—systemic scleroderma	4.94e-05	0.00032	CcSEcCtD
Sumatriptan—Rash—Lisinopril—systemic scleroderma	4.94e-05	0.00032	CcSEcCtD
Sumatriptan—Convulsion—Prednisone—systemic scleroderma	4.94e-05	0.00032	CcSEcCtD
Sumatriptan—Dermatitis—Lisinopril—systemic scleroderma	4.94e-05	0.000319	CcSEcCtD
Sumatriptan—Mediastinal disorder—Methotrexate—systemic scleroderma	4.93e-05	0.000319	CcSEcCtD
Sumatriptan—Asthenia—Mycophenolate mofetil—systemic scleroderma	4.93e-05	0.000319	CcSEcCtD
Sumatriptan—Hypertension—Prednisone—systemic scleroderma	4.92e-05	0.000319	CcSEcCtD
Sumatriptan—Chills—Methotrexate—systemic scleroderma	4.91e-05	0.000318	CcSEcCtD
Sumatriptan—Headache—Lisinopril—systemic scleroderma	4.91e-05	0.000318	CcSEcCtD
Sumatriptan—Pruritus—Mycophenolate mofetil—systemic scleroderma	4.86e-05	0.000314	CcSEcCtD
Sumatriptan—Arthralgia—Prednisone—systemic scleroderma	4.85e-05	0.000314	CcSEcCtD
Sumatriptan—Myalgia—Prednisone—systemic scleroderma	4.85e-05	0.000314	CcSEcCtD
Sumatriptan—Anxiety—Prednisone—systemic scleroderma	4.84e-05	0.000313	CcSEcCtD
Sumatriptan—Discomfort—Prednisone—systemic scleroderma	4.8e-05	0.00031	CcSEcCtD
Sumatriptan—Erythema—Methotrexate—systemic scleroderma	4.77e-05	0.000308	CcSEcCtD
Sumatriptan—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	4.7e-05	0.000304	CcSEcCtD
Sumatriptan—Dysgeusia—Methotrexate—systemic scleroderma	4.67e-05	0.000302	CcSEcCtD
Sumatriptan—Nausea—Lisinopril—systemic scleroderma	4.65e-05	0.000301	CcSEcCtD
Sumatriptan—Oedema—Prednisone—systemic scleroderma	4.65e-05	0.000301	CcSEcCtD
Sumatriptan—Anaphylactic shock—Prednisone—systemic scleroderma	4.65e-05	0.000301	CcSEcCtD
Sumatriptan—Infection—Prednisone—systemic scleroderma	4.62e-05	0.000299	CcSEcCtD
Sumatriptan—Back pain—Methotrexate—systemic scleroderma	4.61e-05	0.000298	CcSEcCtD
Sumatriptan—Shock—Prednisone—systemic scleroderma	4.58e-05	0.000296	CcSEcCtD
Sumatriptan—Nervous system disorder—Prednisone—systemic scleroderma	4.56e-05	0.000295	CcSEcCtD
Sumatriptan—Tachycardia—Prednisone—systemic scleroderma	4.54e-05	0.000294	CcSEcCtD
Sumatriptan—Dizziness—Mycophenolate mofetil—systemic scleroderma	4.54e-05	0.000294	CcSEcCtD
Sumatriptan—Skin disorder—Prednisone—systemic scleroderma	4.52e-05	0.000292	CcSEcCtD
Sumatriptan—Hyperhidrosis—Prednisone—systemic scleroderma	4.5e-05	0.000291	CcSEcCtD
Sumatriptan—Ill-defined disorder—Methotrexate—systemic scleroderma	4.42e-05	0.000286	CcSEcCtD
Sumatriptan—Anaemia—Methotrexate—systemic scleroderma	4.4e-05	0.000285	CcSEcCtD
Sumatriptan—Vomiting—Mycophenolate mofetil—systemic scleroderma	4.37e-05	0.000282	CcSEcCtD
Sumatriptan—Rash—Mycophenolate mofetil—systemic scleroderma	4.33e-05	0.00028	CcSEcCtD
Sumatriptan—Dermatitis—Mycophenolate mofetil—systemic scleroderma	4.33e-05	0.00028	CcSEcCtD
Sumatriptan—Headache—Mycophenolate mofetil—systemic scleroderma	4.3e-05	0.000278	CcSEcCtD
Sumatriptan—Malaise—Methotrexate—systemic scleroderma	4.3e-05	0.000278	CcSEcCtD
Sumatriptan—Vertigo—Methotrexate—systemic scleroderma	4.28e-05	0.000277	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Prednisone—systemic scleroderma	4.24e-05	0.000274	CcSEcCtD
Sumatriptan—Paraesthesia—Prednisone—systemic scleroderma	4.18e-05	0.00027	CcSEcCtD
Sumatriptan—Cough—Methotrexate—systemic scleroderma	4.16e-05	0.000269	CcSEcCtD
Sumatriptan—Convulsion—Methotrexate—systemic scleroderma	4.13e-05	0.000267	CcSEcCtD
Sumatriptan—Nausea—Mycophenolate mofetil—systemic scleroderma	4.08e-05	0.000264	CcSEcCtD
Sumatriptan—Myalgia—Methotrexate—systemic scleroderma	4.06e-05	0.000263	CcSEcCtD
Sumatriptan—Arthralgia—Methotrexate—systemic scleroderma	4.06e-05	0.000263	CcSEcCtD
Sumatriptan—Chest pain—Methotrexate—systemic scleroderma	4.06e-05	0.000263	CcSEcCtD
Sumatriptan—Decreased appetite—Prednisone—systemic scleroderma	4.05e-05	0.000262	CcSEcCtD
Sumatriptan—Fatigue—Prednisone—systemic scleroderma	4.01e-05	0.00026	CcSEcCtD
Sumatriptan—Discomfort—Methotrexate—systemic scleroderma	4.01e-05	0.000259	CcSEcCtD
Sumatriptan—Constipation—Prednisone—systemic scleroderma	3.98e-05	0.000257	CcSEcCtD
Sumatriptan—Confusional state—Methotrexate—systemic scleroderma	3.92e-05	0.000254	CcSEcCtD
Sumatriptan—Anaphylactic shock—Methotrexate—systemic scleroderma	3.89e-05	0.000252	CcSEcCtD
Sumatriptan—Infection—Methotrexate—systemic scleroderma	3.86e-05	0.00025	CcSEcCtD
Sumatriptan—Feeling abnormal—Prednisone—systemic scleroderma	3.84e-05	0.000248	CcSEcCtD
Sumatriptan—Nervous system disorder—Methotrexate—systemic scleroderma	3.81e-05	0.000247	CcSEcCtD
Sumatriptan—Thrombocytopenia—Methotrexate—systemic scleroderma	3.81e-05	0.000246	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Prednisone—systemic scleroderma	3.81e-05	0.000246	CcSEcCtD
Sumatriptan—Skin disorder—Methotrexate—systemic scleroderma	3.78e-05	0.000244	CcSEcCtD
Sumatriptan—Hyperhidrosis—Methotrexate—systemic scleroderma	3.76e-05	0.000243	CcSEcCtD
Sumatriptan—Urticaria—Prednisone—systemic scleroderma	3.7e-05	0.000239	CcSEcCtD
Sumatriptan—Abdominal pain—Prednisone—systemic scleroderma	3.68e-05	0.000238	CcSEcCtD
Sumatriptan—Body temperature increased—Prednisone—systemic scleroderma	3.68e-05	0.000238	CcSEcCtD
Sumatriptan—Hypotension—Methotrexate—systemic scleroderma	3.63e-05	0.000235	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	3.54e-05	0.000229	CcSEcCtD
Sumatriptan—Paraesthesia—Methotrexate—systemic scleroderma	3.49e-05	0.000226	CcSEcCtD
Sumatriptan—Dyspnoea—Methotrexate—systemic scleroderma	3.47e-05	0.000224	CcSEcCtD
Sumatriptan—Somnolence—Methotrexate—systemic scleroderma	3.46e-05	0.000224	CcSEcCtD
Sumatriptan—Hypersensitivity—Prednisone—systemic scleroderma	3.43e-05	0.000222	CcSEcCtD
Sumatriptan—Decreased appetite—Methotrexate—systemic scleroderma	3.38e-05	0.000219	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Methotrexate—systemic scleroderma	3.36e-05	0.000217	CcSEcCtD
Sumatriptan—Fatigue—Methotrexate—systemic scleroderma	3.35e-05	0.000217	CcSEcCtD
Sumatriptan—Asthenia—Prednisone—systemic scleroderma	3.34e-05	0.000216	CcSEcCtD
Sumatriptan—Pain—Methotrexate—systemic scleroderma	3.33e-05	0.000215	CcSEcCtD
Sumatriptan—Pruritus—Prednisone—systemic scleroderma	3.29e-05	0.000213	CcSEcCtD
Sumatriptan—Feeling abnormal—Methotrexate—systemic scleroderma	3.21e-05	0.000207	CcSEcCtD
Sumatriptan—Diarrhoea—Prednisone—systemic scleroderma	3.18e-05	0.000206	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Methotrexate—systemic scleroderma	3.18e-05	0.000206	CcSEcCtD
Sumatriptan—Urticaria—Methotrexate—systemic scleroderma	3.09e-05	0.0002	CcSEcCtD
Sumatriptan—Dizziness—Prednisone—systemic scleroderma	3.08e-05	0.000199	CcSEcCtD
Sumatriptan—Body temperature increased—Methotrexate—systemic scleroderma	3.07e-05	0.000199	CcSEcCtD
Sumatriptan—Abdominal pain—Methotrexate—systemic scleroderma	3.07e-05	0.000199	CcSEcCtD
Sumatriptan—Vomiting—Prednisone—systemic scleroderma	2.96e-05	0.000191	CcSEcCtD
Sumatriptan—Rash—Prednisone—systemic scleroderma	2.93e-05	0.00019	CcSEcCtD
Sumatriptan—Dermatitis—Prednisone—systemic scleroderma	2.93e-05	0.00019	CcSEcCtD
Sumatriptan—Headache—Prednisone—systemic scleroderma	2.92e-05	0.000189	CcSEcCtD
Sumatriptan—Hypersensitivity—Methotrexate—systemic scleroderma	2.87e-05	0.000185	CcSEcCtD
Sumatriptan—Asthenia—Methotrexate—systemic scleroderma	2.79e-05	0.000181	CcSEcCtD
Sumatriptan—Nausea—Prednisone—systemic scleroderma	2.76e-05	0.000179	CcSEcCtD
Sumatriptan—Pruritus—Methotrexate—systemic scleroderma	2.75e-05	0.000178	CcSEcCtD
Sumatriptan—Diarrhoea—Methotrexate—systemic scleroderma	2.66e-05	0.000172	CcSEcCtD
Sumatriptan—Dizziness—Methotrexate—systemic scleroderma	2.57e-05	0.000166	CcSEcCtD
Sumatriptan—Vomiting—Methotrexate—systemic scleroderma	2.47e-05	0.00016	CcSEcCtD
Sumatriptan—Rash—Methotrexate—systemic scleroderma	2.45e-05	0.000159	CcSEcCtD
Sumatriptan—Dermatitis—Methotrexate—systemic scleroderma	2.45e-05	0.000159	CcSEcCtD
Sumatriptan—Headache—Methotrexate—systemic scleroderma	2.44e-05	0.000158	CcSEcCtD
Sumatriptan—Nausea—Methotrexate—systemic scleroderma	2.31e-05	0.000149	CcSEcCtD
